These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 10742383

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Thrombopoietin: expression of its receptor MPL and proliferative effects on leukemic cells.
    Drexler HG, Quentmeier H.
    Leukemia; 1996 Sep; 10(9):1405-21. PubMed ID: 8751457
    [Abstract] [Full Text] [Related]

  • 4. Expression of type 1 insulin-like growth factor receptor in marrow nucleated cells in malignant hematological disorders: correlation with apoptosis.
    Qi H, Xiao L, Lingyun W, Ying T, Yi-Zhi L, Shao-Xu Y, Quan P.
    Ann Hematol; 2006 Feb; 85(2):95-101. PubMed ID: 16328478
    [Abstract] [Full Text] [Related]

  • 5. Circulating myeloid colony-forming cells predict survival in myelodysplastic syndromes.
    Berer A, Jäger E, Sagaster V, Streubel B, Wimazal F, Sperr WR, Welterman A, Schwarzinger I, Frommlet F, Haas OA, Valent P, Lechner K, Geissler K, Ohler L.
    Ann Hematol; 2003 May; 82(5):271-7. PubMed ID: 12739063
    [Abstract] [Full Text] [Related]

  • 6. Plasma thrombopoietin (TPO) levels and expression of TPO receptor on platelets in patients with myelodysplastic syndromes.
    Tamura H, Ogata K, Luo S, Nakamura K, Yokose N, Dan K, Tohyama K, Yoshida Y, Hamaguchi H, Sakamaki H, Kuwaki T, Tahara T, Kato T, Nomura T.
    Br J Haematol; 1998 Dec; 103(3):778-84. PubMed ID: 9858230
    [Abstract] [Full Text] [Related]

  • 7. [Alteration of methylation status of fragile histidine triad gene promoter in patients with myelodysplastic syndrome].
    Yao DM, Qian J, Xu WR, Lin J, Jiang YW, Fei X, Han LX, Wang Y, Cen JN, Chen ZX.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):36-9. PubMed ID: 18247301
    [Abstract] [Full Text] [Related]

  • 8. Characterization of defective megakaryocytic development in patients with myelodysplastic syndromes.
    Hofmann WK, Kalina U, Wagner S, Seipelt G, Ries C, Hoelzer D, Ottmann OG.
    Exp Hematol; 1999 Mar; 27(3):395-400. PubMed ID: 10089900
    [Abstract] [Full Text] [Related]

  • 9. [Wilms' tumor-1 gene expression in myelodysplastic syndrome and its changes in the process of myelodysplastic syndrome transforming into acute leukemia].
    Yang JK, Li JL, Li ZG, Li ZG, Liu PJ, Li JY, Lü HR, Deng Q, Lin XM, Cao JN.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Sep; 15(9):557-9. PubMed ID: 12971856
    [Abstract] [Full Text] [Related]

  • 10. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
    Shi J, Shao ZH, Liu H, Bai J, Cao YR, He GS, Tu MF, Wang XL, Hao YS, Yang TY, Yang CL.
    Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
    [Abstract] [Full Text] [Related]

  • 11. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
    Warlick ED, Cioc A, Defor T, Dolan M, Weisdorf D.
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
    [Abstract] [Full Text] [Related]

  • 12. Expression and function of c-kit receptor in bone marrow mononuclear cells of patients with myelodysplastic syndromes.
    Shao Z, Zhang H, Chen G, Wang L, Li K, Zhang Y, Li L, Sun J.
    Chin Med J (Engl); 2001 May; 114(5):481-5. PubMed ID: 11780408
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prognostic value of c-mpl expression in myelodysplastic syndromes.
    Bouscary D, Preudhomme C, Ribrag V, Melle J, Viguié F, Picard F, Guesnu M, Fenaux P, Gisselbrecht S, Dreyfus F.
    Leukemia; 1995 May; 9(5):783-8. PubMed ID: 7539513
    [Abstract] [Full Text] [Related]

  • 15. Autoantibody to c-Mpl (thrombopoietin receptor) in systemic lupus erythematosus: relationship to thrombocytopenia with megakaryocytic hypoplasia.
    Kuwana M, Okazaki Y, Kajihara M, Kaburaki J, Miyazaki H, Kawakami Y, Ikeda Y.
    Arthritis Rheum; 2002 Aug; 46(8):2148-59. PubMed ID: 12209520
    [Abstract] [Full Text] [Related]

  • 16. Increased expression of c-myc p67 oncoprotein in patients with myelodysplastic syndromes in transformation to acute leukaemia.
    Kyriakou D, Eliopoulos AG, Alexandrakis M, Kalokyri I, Eliopoulos GD.
    Haematologia (Budap); 1996 Aug; 28(1):1-7. PubMed ID: 9283897
    [Abstract] [Full Text] [Related]

  • 17. [Study of thrombopoietin and its receptor C-mpl in acute leukemia].
    Guo Y, Bian S, Luo M.
    Zhonghua Xue Ye Xue Za Zhi; 1999 Mar; 20(3):120-3. PubMed ID: 11601235
    [Abstract] [Full Text] [Related]

  • 18. [Differentiation and expression of membrane hemopoietic cytokine receptors on CD34+ bone marrow cells in patients with myelodysplastic syndromes].
    Li LJ, Fu R, Wang HQ, Yue LZ, Liu H, Wang J, Wang HL, Ruan EB, Qu W, Liang Y, Wang GJ, Wang XM, Liu H, Song J, Wu YH, Xing LM, Guan J, Shao ZH.
    Zhonghua Yi Xue Za Zhi; 2011 Jan 25; 91(4):234-8. PubMed ID: 21418866
    [Abstract] [Full Text] [Related]

  • 19. [The implications of the biological indices examination of bone marrow cells in myelodysplastic syndromes].
    Zhang F, Hao Y, Pang W.
    Zhonghua Xue Ye Xue Za Zhi; 2001 Oct 25; 22(10):528-32. PubMed ID: 11769678
    [Abstract] [Full Text] [Related]

  • 20. [Study on the Characteristics of cell cycle and proliferation of CD34+ hematopoietic stem cells in myelodysplastic syndromes].
    Shi J, Shao ZH, Liu H, Jia HR, Sun J, Bai J, Wu YH, Jing LP, He GS, Cao YR, Wang XL, Tu MF, Hao YS, Yang TY.
    Zhonghua Xue Ye Xue Za Zhi; 2004 Nov 25; 25(11):641-4. PubMed ID: 15634564
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.